{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:48:38Z","timestamp":1787165318042,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s10038-018-0498-8","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T02:18:38Z","timestamp":1534299518000},"page":"1149-1158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Contribution of RAD51D germline mutations in breast and ovarian cancer in Greece"],"prefix":"10.1038","volume":"63","author":[{"given":"Irene","family":"Konstanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentia","family":"Fostira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Apostolou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Stratikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3369-2360","authenticated-orcid":false,"given":"Despoina","family":"Kalfakakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pampanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagoula","family":"Kollia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Konstantopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drakoulis","family":"Yannoukakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"key":"498_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J,\u00a0Ward E,\u00a0Forman D.\u00a0Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"498_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ygyno.2012.09.009","volume":"127","author":"A Wickramanayake","year":"2012","unstructured":"Wickramanayake A, Bernier G, Pennil C, Casadei S,\u00a0Agnew KJ,\u00a0Stray SM, et al. Loss of function germline mutations in RAD51D in women with ovarian carcinoma. Gynecol Oncol. 2012;127:552\u20135.","journal-title":"Gynecol Oncol"},{"key":"498_CR3","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/humu.20599","volume":"28","author":"SJ Ramus","year":"2007","unstructured":"Ramus SJ, Harrington PA, Pye C, DiCioccio RA,\u00a0Cox MJ,\u00a0Garlinghouse-Jones K, et al. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Hum Mutat. 2007;28:1207\u201315.","journal-title":"Hum Mutat"},{"key":"498_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R","volume":"18","author":"AC Antoniou","year":"2000","unstructured":"Antoniou AC, Gayther SA, Stratton JF, Ponder BA,\u00a0Easton DF. Risk models for familial ovarian and breast cancer. Genet Epidemiol. 2000;18:173\u201390.","journal-title":"Genet Epidemiol"},{"key":"498_CR5","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK, Pennil CC,\u00a0Nord AS,\u00a0Thornton AM,\u00a0et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA. 2011;108:18032\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"498_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","volume":"22","author":"L Castera","year":"2014","unstructured":"Castera L, Krieger S, Rousselin A, Legros A,\u00a0Baumann JJ,\u00a0Bruet O,\u00a0et al. Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet. 2014;22:1305\u201313.","journal-title":"Eur J Hum Genet"},{"key":"498_CR7","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1101\/gad.947001","volume":"15","author":"JY Masson","year":"2001","unstructured":"Masson JY, Tarsounas MC, Stasiak AZ, Stasiak A,\u00a0Shah R,\u00a0McIlwraith MJ, et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 2001;15:3296\u2013307.","journal-title":"Genes Dev"},{"key":"498_CR8","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1128\/MCB.21.8.2858-2866.2001","volume":"21","author":"M Takata","year":"2001","unstructured":"Takata M, Sasaki MS, Tachiiri S, Fukushima T,\u00a0Sonoda E,\u00a0Schild D,\u00a0et al. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol. 2001;21:2858\u201366.","journal-title":"Mol Cell Biol"},{"key":"498_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/ng.893","volume":"43","author":"C Loveday","year":"2011","unstructured":"Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR,\u00a0et al. Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet. 2011;43:879\u201382.","journal-title":"Nat Genet"},{"key":"498_CR10","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/bjc.2012.87","volume":"106","author":"DJ Osher","year":"2012","unstructured":"Osher DJ, De Leeneer K, Michils G, Hamel N,\u00a0Tomiak E,\u00a0Poppe B,\u00a0et al. Mutation analysis of RAD51D in non-BRCA1\/2 ovarian and breast cancer families. Br J Cancer. 2012;106:1460\u20133.","journal-title":"Br J Cancer"},{"key":"498_CR11","doi-asserted-by":"publisher","first-page":"e54772","DOI":"10.1371\/journal.pone.0054772","volume":"8","author":"ER Thompson","year":"2013","unstructured":"Thompson ER, Rowley SM, Sawyer S, kConfab,\u00a0Eccles DM,\u00a0Trainer AH, et al. Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer. PLoS ONE. 2013;8:e54772.","journal-title":"PLoS ONE"},{"key":"498_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","volume":"2","author":"BM Norquist","year":"2016","unstructured":"Norquist BM, Harrell MI, Brady MF, Walsh T,\u00a0Lee MK,\u00a0Gulsuner S,\u00a0et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2:482\u201390.","journal-title":"JAMA Oncol"},{"key":"498_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE,\u00a0Wang X,\u00a0Miron P, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015;33:304\u201311.","journal-title":"J Clin Oncol"},{"key":"498_CR14","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A, Patel G,\u00a0Kidd J,\u00a0Brown KL,\u00a0et al. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017;123:1721\u201330.","journal-title":"Cancer"},{"key":"498_CR15","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN,\u00a0Polley EC,\u00a0Na J,\u00a0et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3:1190\u20136.","journal-title":"JAMA Oncol"},{"key":"498_CR16","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.","journal-title":"Nucleic Acids Res"},{"key":"498_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT Dunnen den","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK,\u00a0Greenblatt MS,\u00a0McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37:564\u20139.","journal-title":"Hum Mutat"},{"key":"498_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jmg.2005.033878","volume":"43","author":"SV Tavtigian","year":"2006","unstructured":"Tavtigian SV, Deffenbaugh AM, Yin L,\u00a0Judkins T,\u00a0Scholl T,\u00a0Samollow PB,\u00a0et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2006;43:295\u2013305.","journal-title":"J Med Genet"},{"key":"498_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/nar\/gkj518","volume":"34","author":"E Mathe","year":"2006","unstructured":"Mathe E, Olivier M, Kato S, Ishioka C,\u00a0Hainaut P,\u00a0Tavtigian SV.\u00a0Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Res. 2006;34:1317\u201325.","journal-title":"Nucleic Acids Res"},{"key":"498_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D.\u00a0MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361\u20132.","journal-title":"Nat Methods"},{"key":"498_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1101\/gr.097857.109","volume":"20","author":"KS Pollard","year":"2010","unstructured":"Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A.\u00a0Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010;20:110\u201321.","journal-title":"Genome Res"},{"key":"498_CR22","unstructured":"ExAC Browser (Beta). Exome Aggregation Consortium. \n                    http:\/\/exac.broadinstitute.org\n                    \n                  . Accessed 23 February 2018."},{"key":"498_CR23","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-B\u00e9roud G, Claustres M, B\u00e9roud C.\u00a0Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.","journal-title":"Nucleic Acids Res"},{"key":"498_CR24","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/hmg\/ddl171","volume":"15","author":"PJ Smith","year":"2006","unstructured":"Smith PJ, Zhang C, Wang J, Chew SL,\u00a0Zhang MQ,\u00a0Krainer AR.\u00a0An increased specificity score matrix for the prediction of SF2\/ASF-specific exonic splicing enhancers. Hum Mol Genet. 2006;15:2490\u2013508.","journal-title":"Hum Mol Genet"},{"key":"498_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/1066527041410418","volume":"11","author":"G Yeo","year":"2004","unstructured":"Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol. 2004;11:377\u201394.","journal-title":"J Comput Biol"},{"key":"498_CR26","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/nar\/24.17.3439","volume":"24","author":"SM Hebsgaard","year":"1996","unstructured":"Hebsgaard SM, Korning PG, Tolstrup N, Engelbrecht J,\u00a0Rouz\u00e9 P,\u00a0Brunak S. Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res. 1996;24:3439\u201352.","journal-title":"Nucleic Acids Res"},{"key":"498_CR27","doi-asserted-by":"publisher","first-page":"W285","DOI":"10.1093\/nar\/gkm407","volume":"35","author":"RI Dogan","year":"2007","unstructured":"Dogan RI, Getoor L, Wilbur WJ, Mount SM. SplicePort\u2013an interactive splice-site analysis tool. Nucleic Acids Res. 2007;35:W285\u201391.","journal-title":"Nucleic Acids Res"},{"key":"498_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-7-r145","volume":"8","author":"P Tomancak","year":"2007","unstructured":"Tomancak P, Berman BP, Beaton A, Weiszmann R,\u00a0Kwan E,\u00a0Hartenstein V,\u00a0et al. Global analysis of patterns of gene expression during Drosophila embryogenesis. Genome Biol. 2007;8:R145.","journal-title":"Genome Biol"},{"key":"498_CR29","doi-asserted-by":"publisher","first-page":"W252","DOI":"10.1093\/nar\/gku340","volume":"42","author":"M Biasini","year":"2014","unstructured":"Biasini M, Bienert S, Waterhouse A, Arnold K,\u00a0Studer G,\u00a0Schmidt T, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014;42:W252\u20138.","journal-title":"Nucleic Acids Res"},{"key":"498_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T,\u00a0et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature"},{"key":"498_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/gim.2017.37","volume":"19","author":"K Nykamp","year":"2017","unstructured":"Nykamp K, Anderson M, Powers M, Garcia J,\u00a0Herrera B,\u00a0Ho YY, et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med. 2017;19:1105\u201317.","journal-title":"Genet Med"},{"key":"498_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ajhg.2016.03.024","volume":"98","author":"LM Amendola","year":"2016","unstructured":"Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD,\u00a0et al. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing Exploratory research consortium. Am J Hum Genet. 2016;98:1067\u201376.","journal-title":"Am J Hum Genet"},{"key":"498_CR33","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","volume":"33","author":"H Song","year":"2015","unstructured":"Song H, Dicks E, Ramus SJ, Tyrer JP,\u00a0Intermaggio MP,\u00a0Hayward J, et al. Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population. J Clin Oncol. 2015;33:2901\u20137.","journal-title":"J Clin Oncol"},{"key":"498_CR34","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nsmb795","volume":"11","author":"AB Conway","year":"2004","unstructured":"Conway AB, Lynch TW, Zhang Y, Fortin GS,\u00a0Fung CW,\u00a0Symington LS, et al. Crystal structure of a Rad51 filament. Nat Struct Mol Biol. 2004;11:791\u20136.","journal-title":"Nat Struct Mol Biol"},{"key":"498_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2007.01.010","volume":"11","author":"T Walsh","year":"2007","unstructured":"Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell. 2007;11:103\u20135.","journal-title":"Cancer Cell"},{"key":"498_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrc2946","volume":"10","author":"DD Bowtell","year":"2010","unstructured":"Bowtell DD. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer. 2010;10:803\u20138.","journal-title":"Nat Rev Cancer"},{"key":"498_CR37","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.clbc.2014.08.005","volume":"15","author":"JL Baker","year":"2015","unstructured":"Baker JL, Schwab RB, Wallace AM, Madlensky L. Breast cancer in a RAD51D mutation carrier: case report and review of the literature. Clin Breast Cancer. 2015;15:e71\u20135.","journal-title":"Clin Breast Cancer"},{"key":"498_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ygyno.2017.08.030","volume":"147","author":"J Lilyquist","year":"2017","unstructured":"Lilyquist J, LaDuca H, Polley E, \u00a0Davis BT,\u00a0Shimelis H,\u00a0Hu C, et al. Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls. Gynecol Oncol. 2017;147:375\u201380.","journal-title":"Gynecol Oncol"},{"key":"498_CR39","doi-asserted-by":"publisher","first-page":"e0186043","DOI":"10.1371\/journal.pone.0186043","volume":"12","author":"P Harter","year":"2017","unstructured":"Harter P, Hauke J, Heitz F, Reuss A,\u00a0Kommoss S,\u00a0Marm\u00e9 F, et al. Prevalence of deleterious germline variants in risk genes including BRCA1\/2 in consecutive ovarian cancer patients (AGO-TR-1). PLoS ONE. 2017;12:e0186043.","journal-title":"PLoS ONE"},{"key":"498_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/jmedgenet-2012-100852","volume":"49","author":"LM Pelttari","year":"2012","unstructured":"Pelttari LM, Kiiski J, Nurminen R, Kallioniemi A,\u00a0Schleutker J,\u00a0Gylfe A,\u00a0et al. A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer. J Med Genet. 2012;49:429\u201332.","journal-title":"J Med Genet"},{"key":"498_CR41","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/ijc.28540","volume":"134","author":"S Gutierrez-Enriquez","year":"2014","unstructured":"Gutierrez-Enriquez S, Bonache S, de Garibay GR, Osorio A,\u00a0Santamari\u00f1a M,\u00a0Ram\u00f3n y Cajal T, et al. About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants. Int J Cancer. 2014;134:2088\u201397.","journal-title":"Int J Cancer"},{"key":"498_CR42","first-page":"2113","volume":"5","author":"M Ollier","year":"2015","unstructured":"Ollier M, Radosevic-Robin N, Kwiatkowski F, Ponelle F,\u00a0Viala S,\u00a0Privat M, et al. DNA repair genes implicated in triple negative familial non-BRCA1\/2 breast cancer predisposition. Am J Cancer Res. 2015;5:2113\u201326.","journal-title":"Am J Cancer Res"},{"key":"498_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","volume":"15","author":"MB Daly","year":"2017","unstructured":"Daly MB, Pilarski R, Berry M, Buys SS,\u00a0Farmer M,\u00a0Friedman S, et al. NCCN guidelines insights: genetic\/familial high-risk assessment: breast and ovarian, version 2.2017. J Natl Compr Canc Netw. 2017;15:9\u201320.","journal-title":"J Natl Compr Canc Netw"},{"key":"498_CR44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrclinonc.2010.116","volume":"7","author":"S Banerjee","year":"2010","unstructured":"Banerjee S, Kaye SB, Ashworth A. Making the best of PARP inhibitors in ovarian cancer. Nat Rev Clin Oncol. 2010;7:508\u201319.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0498-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0498-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0498-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:06:27Z","timestamp":1684602387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-018-0498-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1038\/s10038-018-0498-8","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"16 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}